期刊文献+

胰岛素注射液与注射用头孢地嗪钠配伍的稳定性 被引量:3

Compatible Stability of Insulin Injection Mixing with Cefodizime Sodium for Injection
暂未订购
导出
摘要 目的:考察胰岛素注射液与注射用头孢地嗪钠在5%葡萄糖注射液中配伍稳定性。方法:观察配伍液外观、测定配伍液pH,不溶性微粒数等,采用HPLC法测定头孢地嗪钠含量,用化学发光免疫法测定胰岛素含量。结果:配伍液在6 h内无明显外观、pH,头孢地嗪钠含量的变化;但不溶性微粒(≥10μm)数在5 h后超过25个/ml,胰岛素含量在4 h后变化超过10%。结论:胰岛素注射液与头孢地嗪钠在5%葡萄糖注射液中室温下可配伍应用,但应在4 h内用完。 Objective: To study the compatible stability of insulin injection mixing with cefodizime sodium for injection in 5% glucose injection. Method: The appearance of mixed solution, pH and the count of the insoluble particles were monitored, cefodizime sodium was determined by HPLC, and insulin was determined by chemiluminescence immunoassay. Result: There was no significant changes in appearance ,pH and the content of cefodizime sodium within 6 h,but the count of insoluble particles ( ≥10 μm) was over 25 per millilitre 5 h, the content changes of insulin was over 10% after 4 h. Conclusion : Insulin injection mixing with cefodizime sodium for injection in 5% glucose injection can be used at room temperature ,but shoud be used within 4 h.
出处 《中国药师》 CAS 2008年第7期806-808,共3页 China Pharmacist
关键词 头孢地嗪钠 胰岛素 配伍 稳定性 高效液相色谱法 化学发光免疫法 Cefodizime sodium Insulin Compatibility Stability HPLC Chemiluminescence immunoassay
  • 相关文献

参考文献3

二级参考文献16

  • 1..日本抗生物质医药品基准解说1998年版[S].,1998:152~154..
  • 2Aljada A, Saadeh R, Assian E, et al. Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J Clin Endocrinol Metab,2000,85:2572-2575.
  • 3Yudkin JS, Panahloo A, Stehouwer C, et al. The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects. Diabetologia, 2000,43: 1099-1106.
  • 4Dandona P, Aljada A, Mohanty P, et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-infiammatory effect? J Clin Endocrinol Metab,2001,86:3257-3265.
  • 5Ghanim H, Mohanty F, Aljada A, et al. Insulin reduce the pro-inflammatory transcription factor ,activation protein-1 (AP-1), in mononuclear cells (MNC) and plasma matrix metalloproteinase-9 (MMP-9) concentration. Diabetes,2001,50(Suppl 2): A408.
  • 6Aljada A, Ghanim H, Mohanty P, et al. Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (IF) and plasminogen activator inhibitor-1 (PAI-1)
  • 7Gao F, Gao E, Yue IL, et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: The roles of PI3-Kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation, 2002,105:1497-1502.
  • 8Ishikawa O, Kubota Y, Miyachi Y. Prostaglandin E1 suppresses tumor necrosis factor-alpha and interleukin-10 production by lipopolysaccharides-stimulated mononuclear cells. Eur J Pharmacol 1998 ;344:95
  • 9Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature, 2000,405:458-462.
  • 10Begum N,Song Y, Rienzie J, et al. Vascular smooth muscle cell growth and insulin regulation of mitogen-activaed protein kinase in hypertension. Am J Physiol, 1998,275, C42-C49

共引文献428

同被引文献32

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部